Vimarsana
Biggest News Aggregation in the World

Devika Syamnath News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Devika Syamnath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Devika Syamnath Today - Breaking & Trending Today

Tech Stocks Propel S&P 500 and Nasdaq to New Highs Amid Rate Cut Speculation - Vimarsana News

Tech Stocks Propel S&P 500 and Nasdaq to New Highs Amid Rate Cut Speculation

The S&P 500 and Nasdaq achieved record highs for the fourth consecutive session, driven by strong technology shares. Despite a rise in U.S. unemployment claims, lower producer prices have fuelled hopes for a Federal Reserve rate cut in September. Broadcom and Nvidia shares soared, highlighting the tech sector's dominance.

Battles over CEO pay across the globe - Vimarsana News

Battles over CEO pay across the globe

Tesla shareholders will vote on CEO Elon Musk's $56 billion pay package on June 13 that a Delaware judge voided in January, calling the sum unfathomable and because she found the billionaire...

Factbox-Battles over CEO pay across the globe - Vimarsana News

Factbox-Battles over CEO pay across the globe

(Reuters) - Tesla shareholders will vote on CEO Elon Musk's $56 billion pay package on June 13 that a Delaware judge voided in January, calling the sum "unfathomable" and because she found the billionaire improperly controlled the process. Musk's p...

EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review - Vimarsana News

EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review

Sanofi and partner Regeneron Pharmaceuticals have secured the European regulator's backing for use of Dupixent in patients with a chronic lung disease even as the U.S. Food and Drug Administration ...

Birkenstock raises annual revenue forecast - Vimarsana News

Birkenstock raises annual revenue forecast

Birkenstock raised its annual revenue forecast on Thursday, as the German sandal maker bets on benefits from full-price selling and strong demand for its closed-toe silhouettes and cork-based...